UNICYCIVE THERAPEUTICS INC.

Lobbying client · California · filed 2026 to 2026

Clinical-stage biopharmaceutical company focused on novel therapies for kidney disease.

$40,000 Reported spend

3 Filings counted

2 Outside firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

Who filed for this client 2

ARNOLD & PORTER KAYE SCHOLER LLP $40,000 Outside firm · 2 filings
THE KPM GROUP DC LLC $0 Outside firm · 1 filing

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2026 $40,000 3 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 3 total

Registration

THE KPM GROUP DC LLC

3rd Quarter 2026 (July 1 - Sep 30) · posted Nov 6, 2026

View → Q3 report

ARNOLD & PORTER KAYE SCHOLER LLP

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 19, 2026

View → Registration

ARNOLD & PORTER KAYE SCHOLER LLP

3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 5, 2026

View →

Keep going

Filings through November 6, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.